Patent directory · USPTO A61K / A61P
Patents matching “anti-”
1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12227581
Anti-BCMA single domain antibodies and application thereof
granted -
US 12226490
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class
granted -
WO 2025027551
VACCIN ANTI-IBV AVEC PROTÉINE DE SPICULE DE DMV/1639 HÉTÉROLOGUE
granted -
US 12215169
Anti-complement C1s antibodies and uses thereof
granted -
US 12209138
Anti-CD38 antibodies
granted -
US 12209120
Activatable anti-VEGF scFv
granted -
US 12209135
Anti-CD45 antibodies and conjugates thereof
granted -
US 12202883
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12194078
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
granted -
US 12187815
Anti-inflammatory nanofibers
granted -
US 12187779
Anti-human papillomavirus 16 E6 T cell receptors
granted -
US 12173078
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
granted -
US 12173079
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
granted -
US 12173058
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
granted -
US 12173088
Anti-microbial peptides
granted -
US 12172038
Anti-coronavirus antibodies and methods of use
granted -
US 12168054
Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody
granted -
WO 2024249235
CONJUGUÉS ANTICORPS-MÉDICAMENT D'AGENT DE DÉGRADATION DE BET ANTI-CD33 HUMAIN
granted -
WO 2024243450
MÉTHODES DE TRAITEMENT UTILISANT DES CONJUGUÉS ANTICORPS-MÉDICAMENT ANTI-C-MET
granted -
US 12144813
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
US 12144869
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates
granted -
US 12139543
Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR
granted -
US 12134651
Anti-Ryk antibodies and methods of using the same
granted -
US 12116574
Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
granted